Nanjing Vazyme Biotech Co., Ltd.
SSE:688105.SS
22.71 (CNY) • At close June 13, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||
| Current Assets: | ||||||||
| Cash & Cash Equivalents
| 434.245 | 1,966.89 | 1,544.601 | 1,477.78 | 221.602 | 93.773 | 83.284 | 88.805 |
| Short Term Investments
| 2,221.997 | 1,513.997 | 1,719.253 | 1,975.829 | 795.651 | 0.05 | 9 | 0 |
| Cash and Short Term Investments
| 2,656.242 | 3,480.887 | 3,263.853 | 3,453.609 | 1,017.253 | 93.823 | 83.284 | 88.805 |
| Net Receivables
| 503.13 | 351.93 | 839.625 | 322.32 | 226.236 | 70.917 | 40.134 | 30.144 |
| Inventory
| 362.178 | 346.248 | 364.2 | 242.189 | 132.37 | 53.497 | 28.345 | 16.389 |
| Other Current Assets
| 49.921 | 51.192 | 97.432 | 32.771 | 18.072 | 14.35 | 14.457 | 39.015 |
| Total Current Assets
| 3,571.471 | 4,230.258 | 4,565.109 | 4,050.888 | 1,395.697 | 232.588 | 175.638 | 144.209 |
| Non-Current Assets: | ||||||||
| Property, Plant & Equipment, Net
| 726.066 | 835.551 | 679.478 | 308.985 | 128.496 | 34.658 | 26.325 | 18.082 |
| Goodwill
| 130.491 | 130.491 | 130.491 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 95.187 | 101.241 | 49.698 | 16.65 | 7.422 | 2.294 | 0.691 | 0.724 |
| Goodwill and Intangible Assets
| 225.678 | 231.732 | 180.189 | 16.65 | 7.422 | 2.294 | 0.691 | 0.724 |
| Long Term Investments
| -2,167.163 | 47.298 | -1,696.938 | -1,957.347 | 62.717 | 26.136 | 30.979 | 14.581 |
| Tax Assets
| 146.037 | 106.515 | 67.121 | 24.87 | 9.088 | 27.826 | 15.32 | 8.641 |
| Other Non-Current Assets
| 2,546.574 | 294.819 | 2,210.253 | 2,163.074 | 8.216 | 0.831 | 1.795 | 2.159 |
| Total Non-Current Assets
| 1,477.192 | 1,515.915 | 1,440.102 | 556.232 | 215.939 | 91.745 | 75.11 | 44.187 |
| Total Assets
| 5,048.663 | 5,746.173 | 6,005.212 | 4,607.12 | 1,611.636 | 324.333 | 250.748 | 188.397 |
| Liabilities & Equity: | ||||||||
| Current Liabilities: | ||||||||
| Account Payables
| 90.403 | 146.816 | 318.783 | 118.756 | 58.581 | 16.999 | 12.738 | 5.898 |
| Short Term Debt
| 551.317 | 1,133.962 | 272.209 | 31.248 | 11.051 | 35.689 | 31.16 | 5.544 |
| Tax Payables
| 15.297 | 0.034 | 82.762 | 37.781 | 45.636 | 12.989 | 6.876 | 3.619 |
| Deferred Revenue
| 0 | 55.915 | 214.55 | 236.329 | 178.697 | 40.203 | 6.876 | 14.16 |
| Other Current Liabilities
| 246.314 | 182.776 | 265.765 | 104.443 | 48.441 | 2.614 | 22.375 | 20.959 |
| Total Current Liabilities
| 903.332 | 1,519.504 | 1,154.069 | 387.262 | 239.227 | 108.493 | 80.024 | 36.02 |
| Non-Current Liabilities: | ||||||||
| Long Term Debt
| 143.364 | 106.891 | 127.68 | 59.934 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 48.384 | 21.383 | 19.253 | 16.236 | 15.357 | 11.824 | 2.075 | 0 |
| Deferred Tax Liabilities Non-Current
| 1.259 | 1.511 | 11.186 | 0.874 | 0.098 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 8.715 | 67.603 | 80.915 | 15.524 | 39.951 | 3.997 | 2.57 | 1.554 |
| Total Non-Current Liabilities
| 201.723 | 197.389 | 239.034 | 92.568 | 40.049 | 15.821 | 4.645 | 1.554 |
| Total Liabilities
| 1,105.054 | 1,716.892 | 1,393.104 | 479.83 | 279.276 | 124.314 | 84.669 | 37.574 |
| Equity: | ||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 402.134 | 400.01 | 400.01 | 400.01 | 360 | 15.161 | 15.013 | 14.373 |
| Retained Earnings
| 937.999 | 1,008.618 | 1,579.587 | 1,186.804 | 574.617 | -15.487 | -36.464 | -34.74 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 0 | 222.865 | 134.03 | 112.9 | 200.344 | 187.529 | 0 |
| Other Total Stockholders Equity
| 2,605.111 | 2,620.76 | 2,629.311 | 2,406.446 | 397.743 | 200.344 | 184.767 | 171.189 |
| Total Shareholders Equity
| 3,945.243 | 4,029.388 | 4,608.907 | 4,127.29 | 1,332.361 | 200.019 | 166.078 | 150.822 |
| Total Equity
| 3,943.609 | 4,029.28 | 4,612.108 | 4,127.29 | 1,332.361 | 200.019 | 166.078 | 150.822 |
| Total Liabilities & Shareholders Equity
| 5,048.663 | 5,746.173 | 6,005.212 | 4,607.12 | 1,611.636 | 324.333 | 250.748 | 188.397 |